Joseph McNay - Regenerx Biopharm Independent Director
| RGRXDelisted Stock | USD 0.0009 0.0001 12.50% |
Director
Mr. Joseph C. McNay is Independent Director of the Company. He is currently Chairman, Chief Investment Officer and Managing Principal of Essex Investment Management Company, LLC, positions he has held since 1976 when he founded Essex. He has direct portfolio management responsibilities for a variety of funds and on behalf of private clients. He is also a member of the firms Management Board. Prior to founding Essex, Mr. McNay was Executive Vice President and Director of Endowment Management Research Corporationration from 1967. Prior to that, Mr. McNay was Vice President and Senior Portfolio Manager at the Massachusetts Company. Currently he is serving as Trustee of the Dana Farber Cancer Institute, member of the Childrens Hospital Investment Committee and is on the Board of Brigham Womens Hospital. He received his A.B. degree from Yale University and his M.B.A. degree in finance from the Wharton School of the University of Pennsylvania. The Board believes that Mr. McNays extensive financial experience is valuable to our business and also positions him to contribute to the audit committees understanding of financial matters. since 2002.
| Age | 83 |
| Tenure | 22 years |
| Professional Marks | MBA |
| Phone | 301 208 9191 |
| Web | https://www.regenerx.com |
Regenerx Biopharm Management Efficiency
The company has return on total asset (ROA) of (0.8397) % which means that it has lost $0.8397 on every $100 spent on assets. This is way below average. Regenerx Biopharm's management efficiency ratios could be used to measure how well Regenerx Biopharm manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 1.14 M in liabilities. Regenerx Biopharm has a current ratio of 1.03, suggesting that it may have difficulties to pay its financial obligations when due. Debt can assist Regenerx Biopharm until it has trouble settling it off, either with new capital or with free cash flow. So, Regenerx Biopharm's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Regenerx Biopharm sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Regenerx to invest in growth at high rates of return. When we think about Regenerx Biopharm's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 6 records | DIRECTOR Age | ||
| Jimmie Harvey | Fortress Biotech Pref | 62 | |
| Todd Caven | Regen BioPharma | 52 | |
| Jay Lobell | Fortress Biotech Pref | 51 | |
| Malcolm Hoenlein | Fortress Biotech Pref | 73 | |
| David Barrett | Fortress Biotech Pref | 39 | |
| Kevin Lorenz | Fortress Biotech Pref | N/A | |
Management Performance
| Return On Asset | -0.84 |
Regenerx Biopharm Leadership Team
Elected by the shareholders, the Regenerx Biopharm's board of directors comprises two types of representatives: Regenerx Biopharm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Regenerx. The board's role is to monitor Regenerx Biopharm's management team and ensure that shareholders' interests are well served. Regenerx Biopharm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Regenerx Biopharm's outside directors are responsible for providing unbiased perspectives on the board's policies.
| J Finkelstein, CEO and President and Director | ||
| Nabila Turjman, Ex Affairs | ||
| Don Elsey, Independent Director | ||
| Allan Goldstein, Founder, Chairman, Chief Scientific Advisor and Chairman of Medical and Scientific Advisory Board | ||
| Alessandro Noseda, Director | ||
| Joseph McNay, Independent Director | ||
| Raymond Elsey, Independent Director | ||
| Mauro Bove, Independent Director |
Regenerx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Regenerx Biopharm a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.84 | ||||
| Operating Margin | (19.03) % | ||||
| Current Valuation | 22.91 M | ||||
| Shares Outstanding | 143.55 M | ||||
| Shares Owned By Insiders | 45.99 % | ||||
| Shares Owned By Institutions | 0.01 % | ||||
| Number Of Shares Shorted | 19.19 K | ||||
| Price To Earning | 17.73 X | ||||
| Price To Sales | 261.81 X | ||||
| Revenue | 76.76 K |
Currently Active Assets on Macroaxis
| LTC | Litecoin | |
| STETH | Staked Ether | |
| LINK | Chainlink | |
| XLM | Stellar | |
| CRO | Cronos |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Regenerx OTC Stock
If you are still planning to invest in Regenerx Biopharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Regenerx Biopharm's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stocks Directory Find actively traded stocks across global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance |